Navidea Biopharmaceuticals Inc
NAVB
Market Cap$70.06K
Close$
$-0.02
3183.3% downside
Current Fair Value
3183.3% downsideOvervalued by 3183.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $70,059.00 |
|---|---|
| Enterprise Value | $-1,735,000.00 |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.59 |
| Beta | 2.07 |
| Outstanding Shares | 99,364,154 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | -2844.26 |
| Enterprise Value to EBIT | 0.16 |
| Enterprise Value to Net Income | 3 |
| Total Debt to Enterprise | -1.19 |
| Debt to Equity | -0.63 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Navidea Biopharmaceuticals Inc
CEO: Jed Latkin